Menu

Part I: Accurately Diagnosing Alzheimer’s Disease: Shortcomings of Blood Biomarkers and Need for Definitive, Non-invasive Diagnostic Testing

Author of publication Dr. Daniel Alkon, chief scientific advisor, SDx

Synaps Dx

Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients Prev post

Part II: Accurately Diagnosing Alzheimer’s Disease: Shortcomings of Blood Biomarkers and Need for Definitive, Non-invasive Diagnostic Testing Next post

Part II: Accurately Diagnosing Alzheimer’s Disease: Shortcomings of Blood Biomarkers and Need for Definitive, Non-invasive Diagnostic Testing